Originally published on 360DX.com by Greg Cima, Mar23, 2023. By Greg Cima NEW YORK – Backed by a mix of governmental contracts and VC funding, Irish startup Altratech is laying out a bold vision that its home-use microfluidic tests could replace PCR as the standard for molecular diagnostics. Unlike PCR's Read More
Meet us at our Tri-Con San Diego booth 305 on Mar 6-8, and hear CEO Tara Dalton present our technology at the home-diagnostics session Tues 7th
Hear from our CEO Tara Dalton as she presents our technology in the home diagnostics session on Tuesday 7th of March.Title of session: 'At-Home Next-Generation Molecular Detection with All-Synthetic PNA and CMOS'
Altratech's CTO, Tim Cummins, wins EIC 'Best-Pitch, E-Health' Award at EIC-CUF Healthcare Investor Day. Pictured with Cornelius Schmaltz, Ph.D, Head of Unit EIC Accelerator, EISMEA.